A Pharmacokinetic Study of Native E.coli Asparaginase for Acute Lymphoblastic Leukemia Treated with ThaiPOG Protocol

BACKGROUND: Asparaginase is one of the essential chemotherapies used to treat acute lymphoblastic leukemia (ALL). Asparaginase antibody production may cause a subtherapeutic level and result in an inferior outcome. The aim of this study was to prove the efficacy of current native E.coli asparaginase...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaweephisal, Phumin, Tharnpanich, Trai, Suroengrit, Aphinya, Aungbamnet, Pattramon, Seksarn, Panya, Sosothikul, Darintr, Lauhasurayotin, Supanun, Chiengthong, Kanhatai, Poparn, Hansamon, Techavichit, Piti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858243/
https://www.ncbi.nlm.nih.gov/pubmed/34711008
http://dx.doi.org/10.31557/APJCP.2021.22.10.3309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858243/
https://www.ncbi.nlm.nih.gov/pubmed/34711008
http://dx.doi.org/10.31557/APJCP.2021.22.10.3309

Ejemplares similares